This web page was produced as an assignment for Genetics 677, an undergraduate course in UW Madison
References
1. Frame, S. (2001).GSK3 takes centre stage more than 20 years after its discovery.The Biochemical journal, 359, 1 -16.
2. Kerkela, R. (2008). Deletion of GSK-3 beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyo
blast hyperproliferation. The journal of clinical investigation, 118, iss:11, 3609 -3618
3.Science daily (2008, October 3). Loss of the protein target of lithium disrupts normal mouse embryonic heart development. Retrieved February 1, 2009 from http://www.sciencedaily.com
4. Congenital heart defects. Retrieved January 31, 2009 from http://www.nhlbi.nih.gov/health/dci/index.html 5. National center for biotechnology information http://www.ncbi.nlm.nih.gov/sites
6. Brady, H. and Horgan, J.(1998, January). Lithium and the heart. Chest, 93.1,166-169.
7. Wnt/ beta-catenin signaling. Retrieved February 3, 2009 fromhttp://www.cellsignal.com/reference/pathway/Wnt_beta_Catenin.html
8.Development of GSK-3 inhibitors by GlaxoSmithKline and by Johnson & Johnson. (2003, September 17)Bioportfolio Retrieved February 7, 2009 from http://www.bioportfolio.com
9. BLAST :http://blast.ncbi.nlm.nih.gov/Blast.cgi
10. Homologene:http://www.ncbi.nlm.nih.gov/sites/entrez?db=homologene
11 .Phylogeny fr: http://www.phylogeny.fr
12.Gene Bee: http://www.genebee.msu.su
13.iTOL Interactive Tree of Life: http://itol.embl.de
14. SMART: http://smart.embl-heidelberg.de
15. Pfam: http://pfam.sanger.ac.uk
16. Cohen, L.S., Friedman, J.M. (1994). A reevaluation of risk of in utero exposure to lithium. JAMA.271:146-150
17. Schulte-Merker, S. & Smith, J.C. (1995). Mesoderm formation in response to brachyury requires FGF signaling. Current biology. 5:62-67
18. Hoeflich, K. (2000) Requirement for glycogen synthase kinase-3 beta in cell survival and NF-kapaB activation. Nature. 406:86-90
19.Doble, B. & Woodgett, J. (2003). GSK-3: tricks of the trade for multi-tasking kinase.Journal of cell science 116, 1175-1186
20.Lee, H. & Tsai, J. (August, 3 2007). Glycogen synthase kinase 3α and 3β have distinct functioning during cardiogenesis of Zebrafish embryo. BMC developmental biology, 7:93.
21. Claisse, G. & Charrier, B. (February, 15 2007). The Arabidopsis thaliana GSK3/Shaggy like kinase AtSK3-2 modulates floral cell expansion. Plant Mol Biol 64:113-124.
22. Pierce, S. & Kimelman, D. (1995). Regulation of Spemann organizer formation by the intracellular kinase Xgsk-3. Development 121, 755-765.
23. Dajani,R. (2001). Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105, 721-732.
24. PROSITE: http://www.expasy.ch/prosite
25. ExPASy: http://www.expasy.ch
26. UniProt: http://www.uniprot.org
27. Gene Ontology: http://www.ebi.ac.uk/GO
28. Bax,B.(December 2001).The structure of phosphorylated GSK-3 beta complexed with a peptide, FRATtide, that Inhibits beta-catenin phosphorylation. Structure. 9, 1143-115229.
29. Proteome analyst: http://pasub.cs.ualberta.ca:8080/pa/Subcellular
30. pTarget: http://bioapps.rit.albany.edu/pTARGET
31. TargetP: http://www.cbs.dtu.dk/services/TargetP
32.PSORTII: http://www.psort.org/
33. Motif search:http://motif.genome.jp/
34. GEO database:http://www.ncbi.nlm.nih.gov/geo/
35.Hardt, S. (2002). Glycogen synthase kinase – 3beta a novel regulatorof cardiac hypertrophy and development..Journal of the American heart association, 90, 1055-1063 36. 36.GeneCards: http://www.genecards.org
Back to Home page
Contact information
This webpage was created by: Eva Dimitrova, [email protected]